BioCentury
ARTICLE | Product Development

Cephalon's pain sales

August 13, 2007 7:00 AM UTC

Actiq fentanyl sales grew at an average annual rate of 83% from the time Cephalon acquired the drug via its purchase of Anesta in 2000 until it faced generic competition starting last year. This year,...